✦ LIBER ✦

Surrogate end points for pulmonary arterial hypertension

✍ Scribed by Steven M. Kawut; Harold I. Palevsky

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

End Points and Clinical Trial Design in

✍ Vallerie V. McLaughlin; David B. Badesch; Marion Delcroix; Thomas R. Fleming; Se 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 350 KB

Criteria for surrogate end points

✍ Hua Chen; Zhi Geng; Jinzhu Jia 📂 Article 📅 2007 🏛 Blackwell Publishing 🌐 English ⚖ 528 KB

End points and clinical trial designs in

✍ Marius M Hoeper; Ronald J Oudiz; Andrew Peacock; Victor F Tapson; Sheila G Hawor 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Treatments for pulmonary arterial hypert

✍ Chao Liu; Kunshen Liu; Zhenguo Ji; Gang Liu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 299 KB

Treatment end point determinants for pul

✍ Nasreen Z. Ehtesham; Mohammad Nasiruddin; Ayesha Alvi; Battula K. Kumar; Niyaz A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 418 KB

Criteria for surrogate end points based

✍ Chuan Ju; Zhi Geng 📂 Article 📅 2010 🏛 Blackwell Publishing 🌐 English ⚖ 622 KB